The case highlights a previously undescribed dangerous drug interaction between azimilide and ciprofloxacin leading to QT prolongation and torsades de pointes.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to potential azimilide-ciprofloxacin interaction; hypothesis-generating case report leaves open broader risk assessment.
The presented case report describes a male patient with an implanted cardioverter-defibrillator (ICD) in whom a coadministration of ciprofloxacin and azimilide caused QT interval prolongation and multiple episodes of torsades de pointes (TdP) followed by ICD shocks (arrhythmic storm). The case highlights a not described drug interaction between azimilide and ciprofloxacin, which is believed to be the safest member of fluoroquinolones class.
No takes yet. Share an insight, caveat, or question.
KAŹMIERCZAK et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: